Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Stefan Hallén & John C Clapham. (2009) Cell based in vitro and ex vivo models in metabolic disease drug discovery: nice to have or critical path?. Expert Opinion on Drug Discovery 4:4, pages 417-428.
Read now
Read now
Articles from other publishers (25)
Uwe Grether, Jörg Benz, Thomas Hartung & Doris Roth. 2023. Endocannabinoid Signaling. Endocannabinoid Signaling
145
153
.
Esi Domi, Ana Domi, Massimo Ubaldi, Lorenzo Somaini, Gregory Demopulos, George Gaitanaris & Roberto Ciccocioppo. (2020) Further evidence for the involvement of the PPARγ system on alcohol intake and sensitivity in rodents. Psychopharmacology 237:10, pages 2983-2992.
Crossref
Crossref
Christopher J. Kochansky, Michael J. Lyman, Scott E. Fauty, Katerina Vlasakova & Anil P. D'mello. (2018)
Administration of Fenofibrate Markedly Elevates
Fabp3
in Rat Liver and Plasma and Confounds Its Use as a Preclinical Biomarker of Cardiac and Muscle Toxicity
. Lipids 53:10, pages 947-960.
Crossref
Crossref
Kirstine S Tølbøl, Maria NB Kristiansen, Henrik H Hansen, Sanne S Veidal, Kristoffer TG Rigbolt, Matthew P Gillum, Jacob Jelsing, Niels Vrang & Michael Feigh. (2018) Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis. World Journal of Gastroenterology 24:2, pages 179-194.
Crossref
Crossref
Atsuyoshi Nishina, Masaya Itagaki, Yuusuke Suzuki, Mamoru Koketsu, Masayuki Ninomiya, Daisuke Sato, Takashi Suzuki, Satoshi Hayakawa, Makoto Kuroda & Hirokazu Kimura. (2017) Effects of Flavonoids and Triterpene Analogues from Leaves of Eleutherococcus sieboldianus (Makino) Koidz. ‘Himeukogi’ in 3T3-L1 Preadipocytes. Molecules 22:4, pages 671.
Crossref
Crossref
Xiao-Rong Peng, Peter Gennemark, Gavin O’Mahony & Stefano Bartesaghi. (2015) Unlock the Thermogenic Potential of Adipose Tissue: Pharmacological Modulation and Implications for Treatment of Diabetes and Obesity. Frontiers in Endocrinology 6.
Crossref
Crossref
Jos? Pablo Miramontes Gonz?lez, Clara Cieza Borrella, Rafael Mayoral, Luis Corral Gudino, Ciel Makena Hoghtower & Rogelio Gonz?lez Sarmiento. (2014) PPAR gamma pro12Ala polymorphism and type 2 diabetes: a study in a spanish cohort. Journal of Genetics Study 2:1, pages 1.
Crossref
Crossref
Colin A. Flaveny, Laura A. Solt, Douglas J. Kojetin & Thomas P. Burris. 2014. Biased Signaling in Physiology, Pharmacology and Therapeutics. Biased Signaling in Physiology, Pharmacology and Therapeutics
103
135
.
Thomas P. Burris, Laura A. Solt, Yongjun Wang, Christine Crumbley, Subhashis Banerjee, Kristine Griffett, Thomas Lundasen, Travis Hughes & Douglas J. Kojetin. (2013) Nuclear Receptors and Their Selective Pharmacologic Modulators. Pharmacological Reviews 65:2, pages 710-778.
Crossref
Crossref
Tom J Hazell, Jason R DeGuire & Hope A Weiler. (2012) Vitamin D: an overview of its role in skeletal muscle physiology in children and adolescents. Nutrition Reviews 70:9, pages 520-533.
Crossref
Crossref
Hee-Oon Han, Jong-Sung Koh, Seung-Hae Kim, Ok-Ku Park, Kyoung-Hee Kim, Sang-Kweon Jeon, Gwong-Cheung Hur, Hyeon-Joo Yim & Geun-Tae Kim. (2012) Design and Synthesis of Oxime Ethers of ?-Oxo-?-phenylbutanoic Acids as PPAR ? and -? Dual Agonists. Bulletin of the Korean Chemical Society 33:6, pages 1979-1982.
Crossref
Crossref
Stephen J Nicholls & Kiyoko Uno. (2012) Peroxisome proliferator-activated receptor (PPAR ?/?) agonists as a potential target to reduce cardiovascular risk in diabetes. Diabetes and Vascular Disease Research 9:2, pages 89-94.
Crossref
Crossref
Hong Chen, Beatriz Dardik, Ling Qiu, Xianglin Ren, Shari L. Caplan, Bryan Burkey, Brian R. Boettcher & Jesper Gromada. (2010) Cevoglitazar, a Novel Peroxisome Proliferator-Activated Receptor-α/γ Dual Agonist, Potently Reduces Food Intake and Body Weight in Obese Mice and Cynomolgus Monkeys. Endocrinology 151:7, pages 3115-3124.
Crossref
Crossref
Yann Lamotte, Paul Martres, Nicolas Faucher, Alain Laroze, Didier Grillot, Nicolas Ancellin, Yannick Saintillan, Véronique Beneton & Robert T. GampeJr.Jr.. (2010) Synthesis and biological activities of novel indole derivatives as potent and selective PPARγ modulators. Bioorganic & Medicinal Chemistry Letters 20:4, pages 1399-1404.
Crossref
Crossref
Agustin Casimiro-Garcia, Christopher F. Bigge, Jo Ann Davis, Teresa Padalino, James Pulaski, Jeffrey F. Ohren, Patrick McConnell, Christopher D. Kane, Lori J. Royer, Kimberly A. Stevens, Bruce Auerbach, Wendy Collard, Christine McGregor & Kun Song. (2009) Synthesis and evaluation of novel ?-heteroaryl-phenylpropanoic acid derivatives as PPAR?/? dual agonists. Bioorganic & Medicinal Chemistry 17:20, pages 7113-7125.
Crossref
Crossref
Daniela P. Foti, Francesco Paonessa, Eusebio Chiefari & Antonio Brunetti. (2009)
New Target Genes for the Peroxisome Proliferator-Activated Receptor-
(PPAR
) Antitumour Activity: Perspectives from the Insulin Receptor
. PPAR Research 2009, pages 1-8.
Crossref
Crossref
Agustin Casimiro-Garcia, Christopher F. Bigge, Jo Ann Davis, Teresa Padalino, James Pulaski, Jeffrey F. Ohren, Patrick McConnell, Christopher D. Kane, Lori J. Royer, Kimberly A. Stevens, Bruce J. Auerbach, Wendy T. Collard, Christine McGregor, Stephen A. Fakhoury, Robert P. Schaum & Hairong Zhou. (2008) Effects of modifications of the linker in a series of phenylpropanoic acid derivatives: Synthesis, evaluation as PPARα/γ dual agonists, and X-ray crystallographic studies. Bioorganic & Medicinal Chemistry 16:9, pages 4883-4907.
Crossref
Crossref
Ferruh Artunc, Diana Sandulache, Omaima Nasir, Krishna M. Boini, Björn Friedrich, Norbert Beier, Edith Dicks, Sven Pötzsch, Karin Klingel, Kerstin Amann, Bonnie L. Blazer-Yost, Wolfgang Scholz, Teut Risler, Dietmar Kuhl & Florian Lang. (2008) Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARγ agonist pioglitazone. Pflügers Archiv - European Journal of Physiology 456:2, pages 425-436.
Crossref
Crossref
Maria E Ramos-Nino, Charles D MacLean & Benjamin Littenberg. (2007) Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System. BMC Medicine 5:1.
Crossref
Crossref
Vishwajeet Puri, Silvana Konda, Srijana Ranjit, Myriam Aouadi, Anil Chawla, My Chouinard, Abhijit Chakladar & Michael P. Czech. (2007) Fat-specific Protein 27, a Novel Lipid Droplet Protein That Enhances Triglyceride Storage. Journal of Biological Chemistry 282:47, pages 34213-34218.
Crossref
Crossref
Philip Wickens, Chengzhi Zhang, Xin Ma, Qian Zhao, John Amatruda, William Bullock, Michael Burns, Louis-David Cantin, Chih-Yuan Chuang, Thomas Claus, Miao Dai, Fernando Dela Cruz, David Dickson, Frederick J. Ehrgott, Dongping Fan, Sarah Heald, Martin Hentemann, Christiana I. Iwuagwu, Jeffrey S. Johnson, Ellalahewage Kumarasinghe, David Ladner, Rico Lavoie, Sidney Liang, James N. Livingston, Derek Lowe, Steve Magnuson, Gretchen Mannelly, Ingo Mugge, Herbert Ogutu, Susan Pleasic-Williams, Robert W. Schoenleber, Jeff Shapiro, Tatiana Shelekhin, Laurel Sweet, Christopher Town & Manami Tsutsumi. (2007) Indanylacetic acids as PPAR-δ activator insulin sensitizers. Bioorganic & Medicinal Chemistry Letters 17:15, pages 4369-4373.
Crossref
Crossref
Feng Chang, Linda A Jaber, Helen D Berlie & Mary Beth O'Connell. (2007) Evolution of Peroxisome Proliferator-Activated Receptor Agonists. Annals of Pharmacotherapy 41:6, pages 973-983.
Crossref
Crossref
Hee Oon Han, Seung Hae Kim, Kyoung-Hee Kim, Gwong-Cheung Hur, Hyeon Joo Yim, Hee-Kyung Chung, Sung Ho Woo, Ki Dong Koo, Chang-Seok Lee, Jong Sung Koh & Geun Tae Kim. (2007) Design and synthesis of oxime ethers of α-acyl-β-phenylpropanoic acids as PPAR dual agonists. Bioorganic & Medicinal Chemistry Letters 17:4, pages 937-941.
Crossref
Crossref
Fang Zhang, Brian E. Lavan & Francine M. Gregoire. (2007)
Selective Modulators of PPAR-
Activity: Molecular Aspects Related to Obesity and Side-Effects
. PPAR Research 2007, pages 1-7.
Crossref
Crossref
T. H. Karlsen, K. M. Boberg & E. Schrumpf. 2007. Bile Acids: Biological Actions and Clinical Relevance. Bile Acids: Biological Actions and Clinical Relevance
226
237
.